Prenetics Global Limited

AI Score

0

Unlock

5.32
-0.13 (-2.39%)
At close: Feb 18, 2025, 2:56 PM
5.35
0.56%
Pre-market: Feb 20, 2025, 09:30 AM EST
undefined%
Bid 5.3
Market Cap 65.00M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -3.73
PE Ratio (ttm) -1.43
Forward PE n/a
Analyst Buy
Ask 5.8
Volume 311
Avg. Volume (20D) 15,032
Open 5.48
Previous Close 5.45
Day's Range 5.32 - 5.48
52-Week Range 2.85 - 7.84
Beta undefined

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 69.17% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
4 months ago
+19.13%
Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription
6 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.